Cargando…
Endocrinology and hormone therapy in breast cancer: New insight into estrogen receptor-α function and its implication for endocrine therapy resistance in breast cancer
Estrogen and its receptor (ER) are critical for development and progression of breast cancer. This pathway is targeted by endocrine therapies that either block ER functions or deplete ER's estrogen ligand. While endocrine therapies are very effective, de novo and acquired resistance are still c...
Autores principales: | Schiff, Rachel, Osborne, C Kent |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242145/ https://www.ncbi.nlm.nih.gov/pubmed/16168139 http://dx.doi.org/10.1186/bcr1287 |
Ejemplares similares
-
Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005) -
Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
por: Howell, Anthony, et al.
Publicado: (2004) -
Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
por: Craig Jordan, V, et al.
Publicado: (2003) -
Breast cancer survivals and hormone therapy: estrogen and melatonin
por: Soares, José Maria, et al.
Publicado: (2023) -
The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
por: Xu, Jing, et al.
Publicado: (2023)